2023-07-07 17:02:03 ET
Curaleaf ( OTCPK:CURLF ), responding to speculation about a possible transaction involving the cannabis company, said it regularly examines transactions, including partnerships, possible acquisitions, sales, and mergers with third parties.
There's no guarantee that any potential deal will materialize, Curaleaf said in a statement , responding to a request from the Canadian Investment Regulatory Organization.
The response comes after Reuters first reported Thursday that Cronos Group ( NASDAQ: CRON ) was exploring its options after getting takeover interest from companies including Curaleaf ( OTCPK:CURLF ). Cronos confirmed on Thursday that it had received unsolicited indications of interest from several third parties.
Curaleaf ( OTCPK:CURLF ) rose 16% on Friday, and Cronos ( CRON ) gained almost 7%.
Altria ( MO ) owns a 41% stake in Cronos Group ( CRON ). Altria originally purchased a $1.8 billion stake in Cronos in December of 2018.
More on Cronos Group and Curaleaf
- Cronos Group: Cannabis Bank
- First cannabis super PAC Legalize America launches
- Cronos to exit US CBD market by end of Q2 as cash saving measure
- Curaleaf: Keep The Cannabis Dream Alive
- Curaleaf: High On Catalysts, But Operations Remain A Smoke Show
For further details see:
Curaleaf responds to speculation about potential Cronos talks